Most B-cell malignancies express CD19, and a majority of patients with B-cell malignancies are not cured by current standard therapies. Chimeric antigen receptors (CARs) are fusion proteins consisting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback